VitaPCR™ SARS-CoV-2 Gen 2 Assay
REGISTRATION STATUS
CE-marked (IVDD)
The Pandemic
Coronavirus Disease 2019 (COVID-19), an acute respiratory illness caused by infection with the SARS-CoV-2, was initially reported to WHO in Wuhan, China, on December 31, 2019. The SARS-CoV-2 can be transmitted from person to person through the nose, eyes, or mouth. Furthermore, symptoms of SARS-CoV-2 infection vary. It can be asymptomatic or cause mild illnesses, including a runny nose, sore throat, cough, and fever. However, in severe cases, it can lead to pneumonia, breathing difficulties, or death. To date, millions of people around the world have died from COVID-19.
The Need
As the world continues to combat COVID-19, SARS-CoV-2 testing keeps playing a crucial role in stopping the spread of the virus and future variants. Particularly, a rapid and accurate diagnostic test for SARS-CoV-2 detection at the Point-of-Care becomes essential and generally adopted to help healthcare professionals to make decisions on the spot.
The Solution
VitaPCR™ SARS-CoV-2 Gen 2 Assay based on the proprietary RT-PCR technology provides significantly faster testing results than any other laboratory-based methods with higher accuracy than conventional rapid testing. With less than a minute of hands-on time, the test allows the detection of SARS-CoV-2 in 20 minutes from sample to results. On top of that, the comprehensive results information, including Ct values and fluorescence curves, can help healthcare providers make precise decisions and offer proper treatments in a timely manner.
Usability
- Minimal Training Required
- No additional equipment needed
- Room Temperature Storage
Performance
- High Accuracy
- Short Turnaround Time
- Intuitive result interpretation with Ct value & fluorescence curve
Diagnostic Procedure in 4 Steps
Collect
Collect sample
Lyse
Lyse the sample
thoroughly for 15 times
Transfer
Transfer the sample
Start Run
Results reported in
20 minutes
Collect
Collect sample
Lyse
Lyse the sample
thoroughly for 15 times
Transfer
Transfer the sample
Start Run
Results reported in
20 minutes
Intuitive Result Interpretation
VitaPCR™ SARS-CoV-2 Gen 2 Assay
Catalog No.
PCRAE0120
Technology
rRT-PCR
Quantity
20 tests/box
Targets
N1, N2 – Nucleocapsid Gene
Sample Types
Nasopharyngeal or Oropharyngeal Swabs
Hands-on Time
< 1 min
Turnaround Time
20 mins
Kit Storage
5 – 25 °C / 41 – 77 °F
